Topiramate Augmentation in the Treatment of Obsessive-Compulsive Disorder
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
A 12-week program to examine the effectiveness of topiramate in adjunctive treatment for
adults with obsessive-compulsive disorder and who are currently on serotonin reuptake
inhibitor medications (ages 18-65).
Phase:
Phase 4
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai Montefiore Medical Center